Molecular subtyping of Alzheimer’s disease using RNA sequencing data reveals novel mechanisms and targets

Neff, Ryan A., Wang, Minghui, Vatansever, Sezen, Guo, Lei, Ming, Chen, Wang, Qian, Wang, Erming, Horgusluoglu-Moloch, Emrin +16 more·2021·Science Advances

Cited by (320)

Items 101–200 of 320

  1. Proteomic subtyping of Alzheimer's disease CSF links blood–brain barrier dysfunction to reduced levels of tau and synaptic biomarkers
    Madison C. Bangs, Joshna Dharmendrabhai Gadhavi, Kathleen Carter, Lingyan Ping, Duc M. Duong, Eric B. Dammer, Fang Wu, Anantharaman Shantaraman, Edward J. Fox, Erik C. B. Johnson et al. · 2025 · Alzheimer s & Dementia
  2. Multi-omic molecular profiling and network biology for precision anaesthesiology: a narrative review
    Joseph R. Scarpa, Olivier Elemento · 2023 · British Journal of Anaesthesia
  3. Identification of telomere-related genes associated with aging-related molecular clusters and the construction of a diagnostic model in Alzheimer's disease based on a bioinformatic analysis
    Yang Ruan, Weichao Lv, Shuaiyu Li, Yuzhong Cheng, Duanyang Wang, Chaofeng Zhang, Kuniyoshi Shimizu · 2023 · Computers in Biology and Medicine
  4. Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer’s disease
    Stephen C. Gammie, Albee Messing, Mason A. Hill, Cynthia A. Kelm‐Nelson, Tracy L. Hagemann · 2024 · PLoS ONE
  5. Pathogenesis of Alzheimer's disease and therapeutic strategies involving traditional Chinese medicine
    Shutang Li, Jinfei Yang · 2024 · RSC Medicinal Chemistry
  6. Decoding microglial functions in Alzheimer’s disease: insights from human models
    Chandrika Rao, Stefan Semrau, Valentina Fossati · 2025 · Trends in Immunology
  7. Multi-omic integration reveals cell-type-specific regulatory networks of insulin resistance in distinct ancestry populations
    Peng Xu, Minghui Wang, Neeraj Sharma, Mary E. Comeau, Martin Wabitsch, Carl D. Langefeld, Mete Civelek, Bin Zhang, Swapan K. Das · 2023 · Cell Systems
  8. World Trade Center dust induces nasal and neurological tissue injury while propagating reduced olfaction capabilities and increased anxiety behaviors
    Michelle L. Hernandez, Joshua M. Vaughan, Terry Gordon, Morton Lippmann, Sam Gandy, Lung‐Chi Chen · 2022 · Inhalation Toxicology
  9. Temporal Cortex Microarray Analysis Revealed Impaired Ribosomal Biogenesis and Hyperactivity of the Glutamatergic System: An Early Signature of Asymptomatic Alzheimer's Disease
    Ankita Kumari, Abdul Rahaman, Xin‐An Zeng, Muhammad Adil Farooq, Yanyan Huang, Runyu Yao, Murtaza Ali, Romana Ishrat, Rafat Ali · 2022 · Frontiers in Neuroscience
  10. Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer’s disease in cerebrospinal fluid
    Xiaosen Hou, Yunjie Qiu, Hui Li, Yan Yan, Dongxu Zhao, Simei Ji, Junjun Ni, Jun Zhang, Kefu Liu, Hong Qing et al. · 2025 · Alzheimer s Research & Therapy
  11. On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries
    Sanghun Lee, Julian Hecker, Georg Hahn, Kristina Mullin, Alzheimer’s Disease Neuroimaging Initiative, Sharon Marie Lutz, Rudolph E. Tanzi, Christoph Lange, Dmitry Prokopenko · 2024 · Alzheimer s & Dementia
  12. Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease
    Carmen Peña‐Bautista, Lourdes Álvarez‐Sánchez, Gemma García‐Lluch, Luis Raga, Paola Quevedo, Mar Peretó, Ángel Balaguer, Miguel Baquero, Consuelo Cháfer‐Pericás · 2024 · International Journal of Molecular Sciences
  13. Bioinformatics Analysis of Publicly Available Single-Nuclei Transcriptomics Alzheimer’s Disease Datasets Reveals APOE Genotype-Specific Changes Across Cell Types in Two Brain Regions
    Stella Belonwu, Yaqiao Li, Daniel G. Bunis, Arjun Arkal Rao, Caroline Warly Solsberg, Tomiko Oskotsky, Alice L. Taubes, Brian P. Grone, Kelly A. Zalocusky, Gabriela K. Fragiadakis et al. · 2022 · Frontiers in Aging Neuroscience
  14. Multi‐omics‐based analysis of high grade serous ovarian cancer subtypes reveals distinct molecular processes linked to patient prognosis
    Yuanshuo Alice Wang, Ryan A. Neff, Won‐Min Song, Xianxiao Zhou, Sezen Vatansever, Martin J. Walsh, Shu‐Hsia Chen, Bin Zhang · 2023 · FEBS Open Bio
  15. mosGraphGen: a novel tool to generate multi-omics signaling graphs to facilitate integrative and interpretable graph AI model development
    Heming Zhang, Dekang Cao, Zirui Chen, Xiuyuan Zhang, Yixin Chen, Cole Sessions, Carlos Cruchaga, Philip Payne, Guangfu Li, Michael A. Province et al. · 2024 · Bioinformatics Advances
  16. Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profiles
    Tijms, Betty M, Vromen, Ellen M, Mjaavatten, Olav, Holstege, Henne, Reus, Lianne M, van der Lee, Sven, Wesenhagen, Kirsten EJ, Lorenzini, Luigi, Vermunt, Lisa, Venkatraghavan, Vikram et al. · 2023
  17. Disease-specific selective vulnerability and neuroimmune pathways in dementia revealed by single cell genomics
    Jessica E. Rexach, Yuyan Cheng, Lawrence Chen, Damon Polioudakis, Li‐Chun Lin, Vivianne Mitri, Andrew G. Elkins, Anna Yin, Daniela Calini, Riki Kawaguchi et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  18. mosGraphGPT: a foundation model for multi-omic signaling graphs using generative AI
    Heming Zhang, Di Huang, Emily Chen, Dekang Cao, Tianma Xu, Ben Dizdar, Guangfu Li, Yixin Chen, Philip Payne, Michael A. Province et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Unsupervised deep learning of electronic health records to characterize heterogeneity across Alzheimer disease and related dementias: cross-sectional study
    West, Matthew, Cheng, You, He, Yingnan, Leng, Yu, Magdamo, Colin, Hyman, Bradley T, Dickson, John R, Serrano-Pozo, Alberto, Blacker, Deborah, Das, Sudeshna · 2025 · JMIR Aging
  20. UnCOT-AD: Unpaired Cross-Omics Translation Enables Multi-Omics Integration for Alzheimer’s Disease Prediction
    Abrar Rahman Abir, Sajib Acharjee Dip, Liqing Zhang · 2025 · Briefings in Bioinformatics
  21. Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms
    Paula J. Bice, Kwangsik T. Nho, Nilüfer Ertekin‐Taner, Andrew J. Saykin · 2026 · Molecular Neurodegeneration
  22. An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer’s disease
    Cuixiang Lin, Hong‐Dong Li, Chao Deng, Weisheng Liu, Shannon Erhardt, Fang‐Xiang Wu, Xing‐Ming Zhao, Yuanfang Guan, Jun Wang, Daifeng Wang et al. · 2021 · Briefings in Bioinformatics
  23. Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
    Yuriy Pomeshchik, Erika Velásquez, Jeovanis Gil, Oxana l. Klementieva, Ritha Gidlöf, Marie Sydoff, Silvia Bagnoli, Benedetta Nacmias, Sandro Sorbi, Gunilla Westergren‐Thorsson et al. · 2023 · Acta Neuropathologica Communications
  24. Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics
    Yoonjeong Cha, Mohamedi N. Kagalwala, Jermaine Ross · 2024 · Pharmaceuticals
  25. Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
    Kelley C. Larson, Lauren Herl Martens, Michael Marconi, Christopher Dejesus, Suzanne Bruhn, Thomas A. Miller, Barbara A. Tate, Jonathan M. Levenson · 2024 · Journal of Neuroinflammation
  26. ATP6V1A is required for synaptic rearrangements and plasticity in murine hippocampal neurons
    Alessandro Esposito, Sara Pepe, Maria Sabina Cerullo · 2024 · Acta Physiologica
  27. Exploring the Genetic Heterogeneity of Alzheimer’s Disease: Evidence for Genetic Subtypes
    Elman, Jeremy A., Schork, Nicholas J., Rangan, Aaditya V., for the Alzheimer’s Disease Neuroimaging Initiative · 2024 · Journal of Alzheimer’s Disease
  28. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice
    Kristyn N. Borrelli, Kelly K. Wingfield, Emily J. Yao · 2023 · Neuropharmacology
  29. Association of Retromer Deficiency and Tau Pathology in Down Syndrome
    Mary Elizabeth Curtis, Tiffany Smith, Daohai Yu, Domenico Praticò · 2022 · Annals of Neurology
  30. Network Dynamics‐based Subtyping of Alzheimer's Disease With Microglial Genetic Risk Factors
    Choi, Jae Hyuk, Lee, Jonghoon, Kang, Uiryong, Chang, Hongjun, Cho, Kwang-Hyun · 2024 · Alzheimer's Research & Therapy
  31. The lncRNA Gas5 is an activity-responsive scaffold that mediates cAMP-dependent synaptic plasticity
    Kaushik Chanda, Eddie Grinman, Kaylyn Clark, Abhishek Sadhu, Bindu Raveendra, Supriya Swarnkar, Sathyanarayanan V. Puthanveettil · 2025 · Science Signaling
  32. Single Cell Sequencing Technology and Its Application in Alzheimer’s Disease
    Yuru Han, Congying Huang, Yuhui Pan, Xuefeng Gu · 2024 · Journal of Alzheimer s Disease
  33. Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
    Belén Calvo, Pierre Schembri-Wismayer, María Beatriz Durán Alonso · 2025 · Cells
  34. A high-throughput, quantitative platform using 2D dissociated human cerebral organoids to model neuroinflammation in Alzheimer’s disease
    Meagan N. Olson, Pepper Dawes, Liam F. Murray, Nathaniel Barton, Jonathan Sundstrom, Adrian R. Orszulak, Samantha M. Chigas, Khanh Tran, Aimee J. Aylward, Michele F. Caliandro et al. · 2026 · npj Dementia
  35. Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
    Fuhai Li, Abdallah M. Eteleeb, William Buchser, Guoqiao Wang, Chengjie Xiong, Philip Payne, Eric McDade, Celeste M M. Karch, Oscar Harari, Carlos Cruchaga · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Dopamine Self-Polymerization-Assisted Oriented Antibody Immobilization on a Transistor for Alzheimer’s Disease Diagnosis
    Xinxing Gong, 李成祥, Zijie Zhou et al. · 2026 · Analytical Chemistry
  37. MyBrain-Seq: A Pipeline for MiRNA-Seq Data Analysis in Neuropsychiatric Disorders
    Daniel Pérez-Rodríguez, Roberto Carlos Agís‐Balboa, Hugo López-Fernández · 2023 · Biomedicines
  38. Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer’s Disease-Like Pathology
    Olga A. Snytnikova, Darya V. Telegina, Ekaterina A. Savina · 2023 · Journal of Alzheimer s Disease
  39. Effect of RNA-Seq data normalization on protein interactome mapping for Alzheimer’s disease
    Elif Düz, Tunahan Çakır · 2024 · Computational Biology and Chemistry
  40. Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
    Kitani, Akihiro, Matsui, Yusuke, for the Alzheimer’s Disease Neuroimaging Initiative · 2025 · Alzheimer's Research & Therapy
  41. Integrating imaging and omics for enhanced subtyping of mild cognitive impairment associated with Alzheimer’s disease
    Sotiroula Afxenti, Margarita Zachariou, Efi Athieniti, Anastasia Lambrianides, Marios Pantzaris, George M. Spyrou · 2025 · Journal of Translational Medicine
  42. Semaglutide attenuates neuroinflammation in male mice
    Dylan M. Rausch, Mette Q. Ludwig, Marie Aare Bentsen, Stine N. Hansen, Anna Secher, Dorte Holst, Jaime Moreno, Vivek Das, Kristoffer Lihme Egerod, Anne-Mette Bjerregaard et al. · 2026 · Nature Communications
  43. Inflammatory gene expression profiling in peripheral blood from patients with Alzheimer’s disease reveals key pathways and hub genes with potential diagnostic utility: a preliminary study
    Kelly Cardona, Javier Medina, Mary Orrego Cardozo, Francia Restrepo de Mejía, Xabier Elcoroaristizabal, Carlos Andrés Naranjo Galvis · 2021 · PeerJ
  44. Neurodegeneration: 2022 update
    John F. Crary · 2022 · Free Neuropathology
  45. LRP10 and α-synuclein transmission in Lewy body diseases
    Ana Carreras Mascaro, Martyna M. Grochowska, Valerie Boumeester, Natasja F. J. Dits, Ece Naz Bilgiҫ, Guido J. Breedveld, Leonie J.M. Vergouw, Frank Jan de Jong, Martin E. van Royen, Vincenzo Bonifati et al. · 2024 · Cellular and Molecular Life Sciences
  46. Detecting differential transcript usage in complex diseases with SPIT
    Beril Erdogdu, Ales Varabyou, Stephanie C. Hicks, Steven L. Salzberg, Mihaela Pertea · 2024 · Cell Reports Methods
  47. A Mouse Model of Sporadic Alzheimer’s Disease with Elements of Major Depression
    Н. В. Бобкова, Lyubov N. Chuvakova, V. I. Kovalev, D. Y. Zhdanova, Alina Vadimovna Chaplygina, Alexander P. Rezvykh, Michael B. Evgen’ev · 2024 · Molecular Neurobiology
  48. Proteome-wide copy-number estimation from transcriptomics
    Sweatt, Andrew J, Griffiths, Cameron D, Groves, Sarah M, Paudel, B Bishal, Wang, Lixin, Kashatus, David F, Janes, Kevin A · 2024 · Molecular Systems Biology
  49. Biomarkers of diagnosis, prognosis, pathogenesis, response to therapy: Convergence or divergence? Lessons from Alzheimer's disease and synucleinopathies
    Stefano Luca Sensi, Mirella Russo, Pietro Tiraboschi · 2023 · Handbook of clinical neurology
  50. Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development
    Morteza Abyadeh, Vijay Kumar Yadav, Alaattin Kaya · 2023 · Journal of Alzheimer s Disease
  51. Personalized Protein-Protein Interaction Networks Towards Unraveling the Molecular Mechanisms of Alzheimer’s Disease
    Betül Ceylan, Elif Düz, Tunahan Çakır · 2023 · Molecular Neurobiology
  52. Unraveling the Gordian knot: genetics and the troubled road to effective therapeutics for Alzheimer’s disease
    Linda L. Restifo · 2021 · Genetics
  53. Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer’s disease
    Isabel Castanho, Pourya Naderi Yeganeh, Carles A. Boix, Sarah L. Morgan, Hansruedi Mathys, Dmitry Prokopenko, Bartholomew White, Larisa M. Soto, Giulia Pegoraro, Saloni A. Shah et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Multidomain therapy for Alzheimer’s disease: a scoping review of cognitive decline trials
    Jared C. Roach, Gwênlyn Glusman, Molly K. Rapozo, David A. Merrill, Jennifer E. Bramen, John F. Hodes, Prabha Siddarth, Somayeh Meysami, Shannel H. K. Elhelou, Ryan M. Glatt et al. · 2025 · Molecular Neurodegeneration
  55. Epigenomic subtypes of late-onset Alzheimer’s disease reveal distinct microglial signatures
    Valentin Laroche, Rachel Cavill, Morteza P Kouhsar, Joshua Müller, Rick A. Reijnders, Joshua Harvey, Adam R. Smith, Jennifer L. Imm, Jarno Koetsier, Luke Stephen Weymouth et al. · 2026 · Acta Neuropathologica
  56. Pan-neurodegeneration proteomics reveals disease subtypes and molecular signatures
    Him K. Shrestha, Huan Sun, Jay M. Yarbro, DongGeun Lee, Danting Liu, Erming Wang, Meghan G. McReynolds, Nan Zhang, Boer Xie, Shu Yang et al. · 2026 · Cell
  57. Plasma Proteomic Analysis for Alzheimer’s Disease Biomarkers, Pathways, and Subgroup Identification
    Carmen Peña‐Bautista, Lourdes Álvarez‐Sánchez, Ángel Balaguer, Laura Ferré‐González, Mar Peretó, Miguel Baquero, Consuelo Cháfer‐Pericás · 2025 · Journal of Proteome Research
  58. Pathophysiological Mechanisms Fostering Developmental and Epileptic Encephalopathies (DEE): a Complex Interplay between Genetics, Inflammation and Neurodegeneration
    Antonella Riva, Greta Volpedo, Federico Zara, Anna Fassio, Pasquale Striano, Antonio Falace · 2025 · Current Neurology and Neuroscience Reports
  59. Metabolomics and lipidomics study on serum metabolite signatures in Alzheimer's disease and mild cognitive impairment
    Yingren Mai, Fengjie Huang, Hongyan Mi, Zhiyu Cao, Yiqi Li, Kejun Zhou, Jun Liu, Guoxiang Xie, Wang Liao · 2025 · Neurotherapeutics
  60. Predictive gene expression signatures for Alzheimer’s disease using post-mortem brain tissue
    Ashley Duche, Oliver Tan, Andrius Baskys · 2025 · Frontiers in Aging Neuroscience
  61. RNA m6A Methylation and Alzheimer's Disease: Current Evidence and Future Perspectives
    Wenqi Pan, Yan Chen, Yuesi Xu, Wei‐Min Tong, Yamei Niu · 2024 · Human Brain
  62. Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s disease
    Sergio Branciamore, Grigoriy Gogoshin, Andréi S. Rodin, Amanda Myers · 2024 · Scientific Reports
  63. Patient subtyping analysis of baseline multi-omic data reveals distinct pre-immune states associated with antibody response to seasonal influenza vaccination
    Çiğdem Sevim Bayrak, Christian V. Forst, Drew R. Jones, David Gresham, Smruti Pushalkar, Shaohuan Wu, Christine Vogel, Lara K. Mahal, Elodie Ghedin, Ted M. Ross et al. · 2024 · Clinical Immunology
  64. A Holistic Analysis of Alzheimer’s Disease-Associated lncRNA Communities Reveals Enhanced lncRNA-miRNA-RBP Regulatory Triad Formation Within Functionally Segregated Clusters
    Somenath Sen, Debashis Mukhopadhyay · 2024 · Journal of Molecular Neuroscience
  65. Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer’s Disease-Related Genes
    Jingjing Liang, Bonnie LaFleur, Sadiya Hussainy, George L. Perry · 2023 · Journal of Alzheimer s Disease
  66. Circuit-Wide Gene Network Analysis Reveals Sex-Specific Roles for Phosphodiesterase 1b in Cocaine Addiction
    Collin D. Teague, Tamara Markovic, Xianxiao Zhou, Freddyson J. Martínez-Rivera, Angelica M. Minier-Toribio, Alexander K. Zinsmaier, Nathalia V. Pulido, Kyra H. Schmidt, Kelsey E. Lucerne, Arthur Godino et al. · 2024 · Journal of Neuroscience
  67. Unbiased Classification of the Human Brain Proteome Resolves Distinct Clinical and Pathophysiological Subtypes of Cognitive Impairment
    Lenora A. Higginbotham, Kathleen Carter, Eric B. Dammer, Rafi U. Haque, Erik C. B. Johnson, Duc M. Duong, Luming Yin, Philip L. De Jager, David Alan Bennett, James J. Lah et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  68. C5aR1 antagonism suppresses inflammatory glial gene expression and alters cellular signaling in an aggressive Alzheimer’s model
    Nicole D. Schartz, Heidi Yahan Liang, Klébea Carvalho, Shu‐Hui Chu, Adrian Mendoza‐Arvilla, Tiffany J. Petrisko, Ángela Gómez-Arboledas, Ali Mortazavi, Andrea J. Tenner · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Single-Cell Transcriptomic Profiling Reveals Regional Differences in the Prefrontal and Entorhinal Cortex of Alzheimer’s Disease Brain
    Rui‐Ze Niu, Wan-Qing Feng, Li Chen, Tianhao Bao · 2025 · International Journal of Molecular Sciences
  70. ACE2: Friend or Foe in Post-COVID-19 Neurodegeneration?
    Svetlana V. Kononova, Н. В. Бобкова, Р. А. Полтавцева, Sergey V. Leonov, Gennady T. Sukhikh · 2025 · International Journal of Molecular Sciences
  71. Improving mouse models for the study of Alzheimer's disease
    Alaina M. Reagan, Kristen D. Onos, Sarah E. Heuer, Michael Sasner, Gareth R. Howell · 2022 · Current topics in developmental biology/Current Topics in Developmental Biology
  72. Proteomic Signaling of Dual-Specificity Phosphatase 4 (DUSP4) in Alzheimer’s Disease
    Erming Wang, Allen L. Pan, Pritha Bagchi, Srikant Rangaraju, Nicholas T. Seyfried, Michelle E. Ehrlich, Stephen R. Salton, Bin Zhang · 2024 · Biomolecules
  73. Omada: robust clustering of transcriptomes through multiple testing
    Sokratis Kariotis, Pei Fang Tan, Haiping Lu · 2024 · GigaScience
  74. Multi‐omics analyses highlight molecular differences between clinical and neuropathological diagnoses in Alzheimer's disease
    Hatice Büşra Lüleci̇, Attila Jones, Tunahan Çakır · 2024 · European Journal of Neuroscience
  75. Transcriptome analysis of early‐ and late‐onset Alzheimer's disease in Korean cohorts
    Sang‐Won Han, Jiyun Hwang, Tamina Park, Jung‐Min Pyun, Joo‐Yeon Lee, Jeong Su Park, Paula J. Bice, Shiwei Liu, Sunmin Yun, Jibin Jeong et al. · 2025 · Alzheimer s & Dementia
  76. Association of RDoC dimensions with post mortem brain transcriptional profiles in Alzheimer's disease
    Weiqian Jiang, Jonathan S. Vogelgsang, Shu Dan, Peter T. Durning, Thomas H. McCoy, Sabina Berretta, Torsten Klengel · 2025 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  77. How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?
    Luigi Donato, Domenico Mordà, Concetta Scimone, Simona Alibrandi, Rosalia D’Angelo, Antonina Sidoti · 2023 · Biomedicines
  78. GRPa-PRS: A risk stratification method to identify genetically-regulated pathways in polygenic diseases
    Xiaoyang Li, Brisa Simões Fernandes, Andi Liu · 2023 · medRxiv
  79. Autophagy-lysosomal dysfunction, intraneuronal amyloidosis, and selective neuron death yield senile plaques in preclinical late-onset Alzheimer’s Disease
    Ralph A. Nixon, Ju‐Hyun Lee, Philip H. Stavrides, Sandipkumar Darji, Chris N. Goulbourne, Martin J. Berg, Panaiyur S. Mohan, Dun‐Sheng Yang, Panos Roussos, Cynthia Bleiwas et al. · 2024 · Research Square
  80. Cell type-specific associations with Alzheimer’s Disease conserved across racial and ethnic groups
    Tain Luquez, Jonathan Algoo, Rebecca Chiu, Jason A. Mares, Archana Yadav, Matti Lam, Pallavi Gaur, Xiaoying Lai, Dylan I. Lee, Fahad Paryani et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,187 people
    Lijun An, Alexa Pichet Binette, Inès Hristovska, Gabriele Vilkaite, Yu Xiao, Romina Zendehdel, Zijian Dong, Bart Smets, Rowan Saloner, Shinya Tasaki et al. · 2025 · medRxiv
  82. Endogenously generated Dutch‐type Aβ non‐fibrillar aggregates dysregulate presynaptic neurotransmission in the absence of detectable inflammation
    Emilie L. Castranio, Merina Varghese, Elentina K. Argyrousi, Kuldeep Kumar Tripathi, Yong Huang, Akiko Asada, Linda Söderberg, Erin Bresnahan, David Lerner, Francesca Garretti et al. · 2026 · Alzheimer s & Dementia
  83. Similar Normalizing Effect of HSP70 and YB-1 Stress Proteins on the Brain Transcription of a Mouse Model of Alzheimer’s Disease
    Natalia V. Bobkova, Lyubov N. Chuvakova, Svetlana Viktorovna Kononova, Vladimir I Kovalev, Gennadiy Tikhonovich Sukhikh, Olga G. Zatsepina, Alexander P. Rezvykh, Михаил Б. Евгеньев · 2025 · Molecular Neurobiology
  84. LaGrACE: estimating gene program dysregulation with latent regulatory network
    Minxue Jia, Haiyi Mao, Mengli Zhou, Yu-Chih Chen, P. Benos · 2025 · Molecular Systems Biology
  85. scAGG: Sample-level embedding and classification of Alzheimer's disease from single-nucleus data
    Timo Verlaan, Gerard A. Bouland, Ahmed Essam Mahfouz, Marcel J. T. Reinders · 2025 · Computational and Structural Biotechnology Journal
  86. Integrative gene co-expression network analysis reveals protein-coding and LncRNA genes associated with Alzheimer’s disease pathology
    Fatemeh Zebardast, Michael Peter Sascha Riethmueller, Katja Nowick · 2025 · Scientific Reports
  87. Genetic risk in Alzheimer’s disease
    Yining Pan, Hwayoung Cho, Qian Lou, Wei Zhang, Breton Michael Asken, Qianqian Song · 2026 · npj Systems Biology and Applications
  88. Multi-Dimensional Transcriptomics Reveals the Prominent Role of Neuroinflammation in Alzheimer’s Disease
    Xingyu Wang, Zhouting Rong, Feng Xue · 2026 · International Journal of Molecular Sciences
  89. Cell-type signatures of Alzheimer’s disease shared across population groups
    Tain Luquez, Jonathan Algoo, Rebecca Chiu, Jason A. Mares, Archana Yadav, Matti Lam, Pallavi Gaur, Xiaoying Lai, Dylan I. Lee, Fahad Paryani et al. · 2026 · Nature
  90. Emerging Microglial Therapies and Targets in Clinical Trial
    Ling Yan, Andrea Crotti · 2024 · Advances in neurobiology
  91. Bibliometric and visual analysis of single-cell multiomics in neurodegenerative disease arrest studies
    Jieyan Wang, Shuqing Wang, Qingyu Li, Fei Liu, Yantong Wan, Hui Liang · 2024 · Frontiers in Neurology
  92. Multilayer Analysis of RNA Sequencing Data in Alzheimer’s Disease to Unravel Molecular Mysteries
    Dilara Uzuner, Atılay İlgün, Elif Düz, Fatma Betül Bozkurt, Tunahan Çakır · 2024 · Advances in neurobiology
  93. The Eating Disorders Genetics Initiative 2 (EDGI2): study protocol
    Natasha Berthold, Casey M. MacDermod, L. Thornton, R. Parker, Shantal Anid Cortés Morales, Liv Hog, Hannah L. Kennedy, J. Guintivano, P. Sullivan, James J. Crowley et al. · 2025 · BMC Psychiatry
  94. Meeting report of the fifth annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease Research
    Michael Sasner, Kristen D. Onos, Paul R. Territo, Stacey J. Sukoff Rizzo · 2024 · Alzheimer s & Dementia
  95. Maximizing the utility of brain organoid models and overcoming their perceived limitations
    Tyler J. Wenzel, Darrell D. Mousseau · 2024 · Elsevier eBooks
  96. Single-cell transcriptomic analysis elucidates APOE genotype specific changes across cell types in two brain regions in Alzheimer’s disease
    Stella A. Belonwu, Yaqiao Li, Daniel G. Bunis, Arjun Arkal Rao, Caroline Warly Solsberg, Tomiko Oskotsky, Alice L. Taubes, Brian P. Grone, Kelly A. Zalocusky, Gabriela K. Fragiadakis et al. · 2021 · Research Square
  97. Impaired type I interferon signaling activity implicated in the peripheral blood transcriptome of preclinical Alzheimer’s disease
    Liting Song, Jingqi Chen, Chun‐Yi Zac Lo · 2021 · Research Square
  98. A single-cell atlas of the human brain in Alzheimer’s disease and its implications for personalized drug repositioning
    Guangsheng Pei, Brisa Simões Fernandes, Yin‐Ying Wang, Astrid Marilyn Manuel, Peilin Jia, Zhongming Zhao · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Pathologic subtyping of Alzheimer’s disease brain tissue reveals disease heterogeneity
    Tiffany G. Lam, Sophie K. Ross, Benjamin Ciener, Harrison Xiao, Delaney Flaherty, Annie Lee, Brittany N. Dugger, Hasini Reddy, Andrew F. Teich · 2024 · medRxiv
  100. Multi-omic subtypes of Alzheimer’s dementia are differentially associated with psychological traits
    Andrea R. Zammit, Lei Yu, Victoria N. Poole, Konstantinos Arfanakis, Julie A. Schneider, Vladislav Petyuk, Philip L. De Jager, Rima F Kaddurah-Daouk, Yasser Iturria‐Medina, David Alan Bennett · 2025 · bioRxiv (Cold Spring Harbor Laboratory)